Hope is for everyone.

We want every patient

to become a

Cancer Survivor.

Join our worldwide Community

Co-founded by

Cure51 is HDS labelised

and ISO 27001 certified

ISO 27001 labelHDS labelGDPR label
Four outliers
Two outliers
Two outliers
Three outliers
OUR MISSION

We are a TechBio company dedicated to discover new treatments to cure Cancer for good.

We aim to create the first worldwide database of Cancer survivors to leverage their exceptional biological features and find new drugs.

They are the Outliers.

patient-1
patient-2
patient-3
patient-4
patient-5
patient-6
patient-7
patient-8
patient-9
patient-10
patient-11
Our_mission_Outliers_picture_1
patient-13
patient-14
patient-15
patient-16
patient-17
patient-18
patient-19
patient-20
patient-21
patient-22
patient-23
patient-24
patient-25
patient-26
patient-27
Our_mission_Outliers_picture_2
patient-29
patient-30
patient-31
patient-32
patient-33
patient-34
patient-35
patient-36
patient-37
patient-38
patient-39
patient-40
patient-41
patient-42
patient-43
patient-44
patient-45
patient-46
patient-47
patient-48
patient-49
patient-50
patient-51
patient-52
patient-53
patient-54
Our_mission_Outliers_picture_3
patient-56
patient-57
patient-58
patient-59
patient-60
patient-61
patient-62
patient-63
patient-64
patient-65
patient-66
patient-67
patient-68
patient-69
Our_mission_Outliers_picture_4
transition

Patients with Cancer who respond exceptionally well to therapy may have molecular changes in their tumors that explain their response.

A comprehensive analysis of these Outliers may help to contribute to the development of potential new treatments.

analyse-1
analyse-2
WHAT WE DO

Cure51 focuses on patients

who have survived some of the most lethal Cancers.

brain-picto

Glioblastoma

IDH-wt (GBM)

WWD_patient1
poumon-picto

ES-SCLC

Lung Cancer
Extensive stage

WWD_patient1
pancreas-picto

PDAC

Metastatic pancreatic
Ductal adenocarcinoma

WWD_patient1
transition
OUR NETWORK

We are a TechBio company co-founded with
leading international oncology
centers and researchers from over 36 countries.

Africa_continentAmerica_continentAsia_continentEurope_continentRussiaAustralie

The Americas

  • Argentina
  • Bolivia
  • Brazil
  • Canada
  • Columbia
  • Costa-Rica
  • Mexico
  • Peru
  • USA

Europe

  • Austria
  • Bulgaria
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Italy
  • Netherland
  • Norway
  • Luxembourg
  • Portugal
  • Poland
  • Romania
  • Spain
  • Slovenia
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom

Africa

  • Kenya
  • Morocco
  • Nigeria
  • South Africa
  • Tanzania
  • Tunisia

Asia & Middle-East

  • Israel
  • India
  • Japan
  • Jordan
  • Pakistan
  • Taiwan
  • Thailand
transition
WE ARE A TECHBIO COMPANY

Our proprietary Discovery Platform is a hub
to organize, analyze and discover novel therapeutic targets.

We are building a unique clinical and multi-omics database of Outliers across all continents.

Our computational biology team works with our scientific partners to discover multimodal signatures and create a library of robust targets contributing to the design of best-in-class drugs.

We develop precision medicine tools in order to deliver actionable insights to discover novel therapeutics.

OUR SCIENTIFIC LEADERS

Our Scientific Steering Committee
includes world-renowned oncologists.

We are Cure51

Hope is for everyone.

© 2024 CURE51, All Rights Reserved

About UsPressCareersContact Us

Cure51 is HDS labelised

and ISO 27001 certified

  • ISO 27001 label
  • HDS label
  • GDPR label